En los medios

<p>Elena Meléndez</p>
6 Nov 2017 - El Punt Avui y otros medios

Various media, among them El Punt Avui, Ara and ABC, pick up on the award of the first “IRB Barcelona Futur” fellowship, which stands out for being funded through donations made to the centre.

Elena Meléndez, a 24-year-old student, is the first awardee.

Link to ABC

4 Nov 2017 - Canal Extremadura Radio - Principio de Incertidumbre

The research and science programme “Principio de Incertidumbre” broadcasted by Radio Canal Extremadura has interviewed the ICREA researcher Salvador Aznar Benitah about the circadian rhythm—the subject of the 2017 Nobel Prize in Medicine.

In August, Aznar Benitah’s group published two studies in Cell that rejected the dogma that aging is associated with the loss of the circadian cycle of stem cells.

Link to Radio Canal Extremadura

30 Oct 2017 - Diario Médico

Diario Médico explains, through IRB Barcelona researcher Cristina Pantoja, the research conducted in regenerative medicine in the Cellular Plasticity and Disease laboratory. The specialized newspaper goes on to describe how the incorporation of Manuel Serrano’s lab to IRB Barcelona in May was made possible thanks to the joint effort of ICREA of the Generalitat de Catalunya and the Obra Social "la Caixa".

<p>Manuel Serrano, group leader of the Cellular Plasticity and Disease laboratory at IRB Barcelona.</p>
25 Oct 2017 - Scientific American

Scientific American responds to an article originally published in Nature on senescent cells (which have lost the ability to divide) and their impact on premature aging. The author cites ICREA researcher Manuel Serrano, at IRB Barcelona, who has studied the phenomenon of senescence for more than 25 years.

Link to Scientific American

24 Oct 2017 - Néxt

In an extensive article, the channel of science and technology news Néxt/VózPopuli relates how tycoons in Silicon valley are attempting to buy eternal youth.

Manuel Serrano, researcher at IRB Barcelona, and other experts on ageing consulted, consider that there is an investment “bubble” in the anti-aging research field. “It’s great that wealthy people believe that ageing is a condition that can be treated,” he says. “We are starting to get spectacular results in mice and I think there is a sufficient scientific basis for optimism. If I were rich I would also be investing in this,” he concludes.

Read the article here:...

22 Oct 2017 - La Vanguardia i altres mitjans

Several media, including La Vanguardia, have devoted an article to the fifth edition of the Barcelona Conference on Epigenetics and Cancer (BCEC), which will take place at the CosmoCaixa in Barcelona on 25 and 26 October. Those responsible for B·Debate, an initiative of Biocat and the "la Caixa" Obra Social, have brought together researchers from all over the world for this event. IRB Barcelona is among the driving forces of the BCEC.

Link to La Vanguardia

Link to ...

<p>Salvador Aznar Benitah leads the Stem Cells and Cancer laboratory at IRB Barcelona</p>
20 Oct 2017 - El Mundo & other media

Various media, including El Mundo, have reported on the presentation of the National Research Award of the Caja Rural de Soria Scientific Foundation to ICREA researcher Salvador Aznar-Benitah. During the ceremony, Aznar-Benitah reminded attendees that, according to his research, palmitic acid has the ability to fuel the metastasis of various kinds of cancer. He also stressed, "A bad diet significantly shortens life expectancy."

Link to La Vanguardia

<p>Picture showing the metastasis of a primary breast tumour to bone (Author: Formas Naturales by Inbiomotion, IRB Barcelona)</p>
19 Oct 2017 - La Vanguardia i altres mitjans

Multiple media channels, both national and international, have echoed a study published by Robert E. Coleman (University of Sheffield) in the Lancet Oncology and which involved Roger Gomis (IRB Barcelona). The work allows early detection of patients who could benefit from zoledronic acid and those who should avoid it. Such early detection would thus accelerate the administration of the first preventive treatment for metastasis.

Link to JANO

Link to...

19 Oct 2017 - el Economista

The newspaper el Economista has devoted a column to the first Master's Degree in Experimental Sciences that has been set up by the Barcelona Institute of Science and Technology (BIST) and the Pompeu Fabra University. The programme includes a Winter School on microscopy, nanoscopy and image sciences, which will be given by specialists from ICN2, IRB Barcelona, CRG, ICFO and IFAE.

18 Oct 2017 - Nature

Today Nature Index has published statistics indicating the scientific attractiveness of Barcelona and the scientific rivalry with Madrid. The subheading notes "Barcelona lures scientists, while Madrid is bound by bureaucracy."

Among the different rankings, the report lists the ten best scientific institutions in Barcelona and classifies the Institute of Biomedical Research in eight place. The Institute is one of the four centres participating in Barcelona Institute of Science and Technology (BIST) that appears in the "top ten."